• Home Diagnostics (Fort Lauderdale, Florida) said that it received FDA clearance for its blood glucose meter, TRUE2go, and for TRUEresult, the company's latest advanced-performance, no-coding meter for at-home testing. The TRUE systems feature no-coding technology that helps simplify blood glucose testing by eliminating the need for users to code the meter with each new box of test strips. Both TRUE2go and TRUEresult deliver precise results in as fast as four seconds using only 0.5 microliters of blood. Home Diagnostics makes diabetes management solutions.

• Lumedx (Oakland, California) and Epiphany Cardiography (Amherst, Virginia) introduce CardioECG 3.2, multi-modality, multi-vendor, pure-Web software for cardiac rhythm data management. The software is designed to deliver clinical data from over 60 different devices and over 30 vendors across 10 different modalities such as cardiograph, Holter, stress, patient monitoring, PFT, and defibrillator. The companies claim that the CardioECG 3.2 eliminates expenses associated with regular, costly hardware and software upgrades and sunsetting of older systems; offers pure Web access — edit, review, confirm and print diagnostic-quality ECGs from any network-connected PC in the hospital, office, home or even via iPhone; and enables robust multi-site communications and support without the high costs related to proprietary systems. Lumedx makes cardiovascular imaging and information systems.

No Comments